Product Details

Ondansetron

Ondansetron Hydrochloride
4 mg
Tablet


DIN/PIN/NPN

02541424

Manufacturer

Sivem Pharmaceuticals ULC

Formulary Listing Date

2024-05-31  

Unit Price

3.3495

Amount MOH Pays

2.5450

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

A04AA01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02213567 Zofran 15.4760 2.5450
02376091 Septa-Ondansetron 3.3495 2.5450
02274310 Sandoz Ondansetron 3.3495 2.5450
02312247 Ran-Ondansetron 3.3495 2.5450
02258188 PMS-Ondansetron 3.3495 2.5450
02421402 Ondansetron 3.2720 2.5450
02417839 Nat-Ondansetron 3.3495 2.5450
02297868 Mylan-Ondansetron 3.3495 2.5450
02305259 Mint-Ondansetron 3.3495 2.5450
02371731 Mar-Ondansetron 3.3495 2.5450
02313685 Jamp-Ondansetron 3.3495 2.5450
02458810 CCP-Ondansetron 3.3495 2.5450
02288184 Apo-Ondansetron 3.3495 2.5450
02296349 Teva-Ondansetron 3.3495 2.5450
02478927 Accel-Ondansetron 2.5450 2.5450
02541424 Ondansetron 3.3495 2.5450
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
215 1 year

For the treatment of emesis in cancer patients receiving highly emetogenic chemotherapy

216 1 year

For patients receiving intravenous chemotherapy or radiation therapy who have not experienced adequate control with other available anti-emetics

217 1 year

For patients receiving intravenous chemotherapy or radiation therapy who experience intolerable side effects with other anti-emetics

218 1 year

For the treatment of emesis in patients receiving radiation therapy which consists of single fraction treatment to the abdominal cavity, hemi-body irradiation and total body irradiation.

454 1 year

For the treatment of emesis in cancer patients receiving moderately emetogenic chemotherapy (MEC) regimens

 

EAP Criteria

NO

Product Monograph

View Monograph